NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
12.24
Dollar change
+0.03
Percentage change
0.25
%
IndexRUT P/E- EPS (ttm)-8.36 Insider Own3.21% Shs Outstand46.24M Perf Week1.07%
Market Cap566.03M Forward P/E11.13 EPS next Y1.10 Insider Trans-0.47% Shs Float44.76M Perf Month-3.16%
Enterprise Value609.93M PEG- EPS next Q0.15 Inst Own94.54% Short Float3.73% Perf Quarter-12.26%
Income-384.60M P/S0.82 EPS this Y-37.04% Inst Trans0.99% Short Ratio3.48 Perf Half Y-23.60%
Sales689.20M P/B0.67 EPS next Y29.41% ROA-27.46% Short Interest1.67M Perf YTD-23.12%
Book/sh18.15 P/C5.84 EPS next 5Y- ROE-36.78% 52W High25.36 -51.74% Perf Year-36.18%
Cash/sh2.10 P/FCF4.97 EPS past 3/5Y- -54.63% ROIC-40.04% 52W Low11.75 4.17% Perf 3Y-52.61%
Dividend Est.- EV/EBITDA6.33 Sales past 3/5Y-2.61% -0.28% Gross Margin54.79% Volatility2.12% 2.64% Perf 5Y-59.46%
Dividend TTM- EV/Sales0.88 EPS Y/Y TTM-530.36% Oper. Margin7.63% ATR (14)0.34 Perf 10Y-71.61%
Dividend Ex-Date- Quick Ratio1.56 Sales Y/Y TTM1.34% Profit Margin-55.80% RSI (14)46.91 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio2.57 EPS Q/Q823.08% SMA20-0.53% Beta1.12 Target Price14.00
Payout- Debt/Eq0.17 Sales Q/Q0.84% SMA50-1.84% Rel Volume0.85 Prev Close12.21
Employees2227 LT Debt/Eq0.14 EarningsMay 06 BMO SMA200-26.21% Avg Volume479.71K Price12.24
IPOOct 21, 2014 Option/ShortYes / Yes EPS/Sales Surpr.44.44% 3.55% Trades Volume404,620 Change0.25%
Date Action Analyst Rating Change Price Target Change
Jul-25-23Downgrade KeyBanc Capital Markets Overweight → Sector Weight
May-22-23Initiated CL King Buy $31
Aug-04-21Downgrade Stephens Overweight → Equal-Weight $60 → $45
Apr-13-20Upgrade Barclays Underweight → Equal Weight $30
Nov-07-19Downgrade Stifel Buy → Hold $45 → $35
Nov-06-19Downgrade Raymond James Outperform → Mkt Perform
Oct-16-18Initiated Barclays Equal Weight $69
Aug-21-18Upgrade Raymond James Mkt Perform → Outperform
Jun-09-25 07:15AM
May-13-25 09:16AM
May-09-25 06:51AM
May-07-25 12:50PM
03:12AM
12:33AM Loading…
12:33AM
May-06-25 09:47AM
08:25AM
07:25AM
07:00AM
Apr-28-25 07:47AM
Apr-25-25 04:49AM
Apr-17-25 12:24PM
Apr-03-25 07:54AM
Apr-02-25 07:00AM
11:30AM Loading…
Mar-28-25 11:30AM
Mar-24-25 05:29AM
Mar-17-25 07:30AM
Mar-11-25 10:26AM
Feb-27-25 03:02AM
02:13AM
Feb-26-25 08:25AM
07:33AM
07:00AM
Feb-19-25 08:54AM
Jan-28-25 09:12AM
Jan-27-25 10:07AM
Jan-06-25 08:54AM
Nov-12-24 12:07PM
Nov-11-24 09:38AM
04:16PM Loading…
Nov-08-24 04:16PM
Nov-05-24 07:00AM
Oct-31-24 09:40AM
03:11AM
03:10AM
Oct-30-24 08:00AM
07:00AM
06:45AM
Oct-23-24 06:19AM
Oct-17-24 12:00PM
Oct-09-24 03:32PM
09:40AM
Oct-02-24 08:36AM
Sep-19-24 09:40AM
Sep-13-24 09:50AM
Sep-09-24 10:54AM
10:29AM
Aug-22-24 09:40AM
Aug-12-24 10:36AM
Aug-05-24 09:40AM
Aug-01-24 12:55PM
Jul-31-24 08:20AM
07:16AM
07:00AM
Jul-26-24 12:43PM
Jul-24-24 06:14PM
Jul-01-24 07:00AM
May-13-24 07:15AM
May-06-24 10:54AM
May-03-24 01:14PM
04:21AM
03:31AM
May-02-24 11:56AM
08:47AM
08:25AM
07:24AM
07:00AM
Apr-25-24 11:16AM
Apr-02-24 11:18AM
Feb-21-24 07:18PM
09:37AM
08:59AM
Feb-20-24 07:36AM
07:34AM
07:00AM
Feb-13-24 08:41PM
Jan-05-24 10:15AM
Jan-04-24 08:00AM
Jan-02-24 10:53AM
Dec-01-23 11:31AM
Nov-07-23 01:08PM
Nov-05-23 12:33PM
Nov-02-23 12:25PM
Nov-01-23 10:21PM
09:14AM
07:42AM
07:00AM
Oct-31-23 08:32AM
Oct-25-23 10:02AM
09:30AM
Sep-12-23 06:37AM
Aug-11-23 10:50AM
06:07AM
Aug-10-23 11:22AM
01:25AM
Aug-09-23 08:50AM
07:45AM
07:00AM
Aug-08-23 06:52PM
Aug-02-23 12:31PM
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holbrook KerrSVP, Chief Commercial OfficerMar 06 '25Sale15.257,000106,77882,047Mar 10 11:50 AM
Holbrook KerrOfficerMar 06 '25Proposed Sale15.257,000106,780Mar 06 05:05 PM
James MojiradeSVP, General CounselMar 04 '25Option Exercise0.008,039078,352Mar 06 02:25 PM
Woody Joseph FralinFormer Chief Executive OfficerMar 04 '25Option Exercise0.0032,1580453,203Mar 06 02:25 PM
Holbrook KerrSVP, Chief Commercial OfficerMar 04 '25Option Exercise0.005,145092,393Mar 06 02:24 PM
Hurley John JosephPrincipal Accounting OfficerMar 04 '25Option Exercise0.00107010,172Mar 06 02:23 PM
Greiner MichaelInterim CEOMar 04 '25Option Exercise0.0012,1490214,235Mar 06 02:22 PM